Ferrata Storti Foundation

SHERPA: Unknown

People

  1. Tallman
    Tallman
  2. Levine
    Levine
  3. Zelenetz
    Zelenetz
  4. Mauro
    Mauro
  5. Stein
    Stein
  6. Abdel-Wahab
    Abdel-Wahab
  7. Dogan
    Dogan
  8. Horwitz
    Horwitz
  9. Perales
    Perales
  10. Salles
    Salles

Groups

  1. Department of Medicine (295)
  2. Hematologic Malignancies, Division of (294)
  3. Center for Hematologic Malignancies (270)
  4. Adult Leukemia (107)
  5. Lymphoma (73)
  6. GSK Faculty (70)
  7. Executive Committee, Center for Hematologic Malignancies (60)
  8. Hematologic Malignancies Research (45)
  9. Sloan Kettering Institute Postdocs (43)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (41)
Search Within
Formats
  1. Meeting Abstract (178)
  2. Journal Article (122)
  3. Research Letter (26)
  4. Editorial (17)
  5. Review (12)
  6. Correspondence (1)
  7. Guidelines (1)
Groups
  1. Department of Medicine (295)
  2. Hematologic Malignancies, Division of (294)
  3. Center for Hematologic Malignancies (270)
  4. Adult Leukemia (107)
  5. Lymphoma (73)
  6. GSK Faculty (70)

More Groups

People
  1. Carl Landgren (25)
  2. Martin Tallman (25)
  3. Andrew Zelenetz (24)
  4. Ross Levine (24)
  5. Michael Mauro (21)
  6. Anas Younes (16)

More People

Years
  1. 2025 (17)
  2. 2024 (23)
  3. 2023 (17)
  4. 2022 (20)
  5. 2021 (13)
  6. 2020 (18)

More Years

Publications
  1. Haematologica (353)
  2. Haematologica Meeting Reports (4)

Results (357)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Utility of positron emission tomography-computed tomography in patients with chronic lymphocytic leukemia following B-cell receptor pathway inhibitor therapy
    Journal Article

    Mato, A. R.; Wierda, W. G.; Davids, M. S.; Cheson, B. D.; Coutre, S. E.; Choi, M.; Furman, R. R.; Heffner, L.; Barr, P. M.; Eradat, H.; more...
    Haematologica (2019)

    Fulltext@MSK | Save
  • Which are the most promising targets for minimal residual disease-directed therapy in acute myeloid leukemia prior to allogeneic stem cell transplant?
    Review

    Ball, B.; Stein, E. M.
    Haematologica (2019)

    Fulltext@MSK | Save
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for post-induction measurable residual disease and inferior outcomes in acute myeloid leukemia
    Journal Article

    Xiao, W.; Goldberg, A. D.; Famulare, C. A.; Devlin, S. M.; Nguyen, N. T.; Sim, S.; Kabel, C. C.; Patel, M. A.; McGovern, E. M.; Patel, A.; more...
    Haematologica (2019)

    Fulltext@MSK | Save
  • Mogamulizumab versus investigator's choice of chemotherapy regimen in relapsed/refractory adult T-cell leukemia/lymphoma
    Journal Article

    Phillips, A. A.; Fields, P. A.; Hermine, O.; Ramos, J. C.; Beltran, B. E.; Pereira, J.; Wandroo, F.; Feldman, T.; Taylor, G. P.; Sawas, A.; more...
    Haematologica (2019)

    Fulltext@MSK | Save
  • Next-generation sequencing in the diagnosis and minimal residual disease assessment of acute myeloid leukemia
    Review

    Levine, R. L.; Valk, P. J. M.
    Haematologica (2019)

    Fulltext@MSK | Save
  • Extramedullary acute myeloid leukemia presenting in young adults demonstrates sensitivity to high-dose anthracycline: A subset analysis from ECOG-ACRIN 1900
    Journal Article

    Fernandez, H. F.; Sun, Z.; Litzow, M. R.; Luger, S. M.; Paietta, E.; Racevskis, J.; Levine, R. L.; Patel, J. P.; Abdel-Wahab, O.; Ketterling, R. P.; more...
    Haematologica (2019)

    Fulltext@MSK | Save
  • Clinical presentation determines selection of patients for initial observation in mantle cell lymphoma
    Journal Article

    Kumar, A.; Ying, Z.; Alperovich, A.; Dogan, A.; Hamlin, P.; Moskowitz, C.; Pichardo, J.; Portlock, C.; Sha, F.; Zelenetz, A. D.; more...
    Haematologica (2019)

    Fulltext@MSK | Save
  • Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors
    Journal Article

    Pulsipher, M. A.; Logan, B. R.; Kiefer, D. M.; Chitphakdithai, P.; Riches, M. L.; Rizzo, J. D.; Anderlini, P.; Leitman, O. F.; Kobusingye, H.; Besser, R. M.; more...
    Haematologica (2019)

    Fulltext@MSK | Save
  • ABVD plus rituximab versus ABVD alone for advanced stage, high-risk classical Hodgkin lymphoma: A randomized phase 2 study
    Research Letter

    Strati, P.; Fanale, M. A.; Oki, Y.; Turturro, F.; Fayad, L. E.; Bartlett, N. L.; Gladstone, D. E.; Kasamon, Y. L.; Portlock, C. S.; Wilson, W. H.; more...
    Haematologica (2019)

    Fulltext@MSK | Save
  • Novel iatrogenic amyloidosis caused by peptide drug liraglutide: A clinical mimic of AL amyloidosis
    Journal Article

    Martins, C. O.; Lezcano, C.; Yi, S.; Landau, H. J.; Chapman, J. R.; Dogan, A.
    Haematologica (2018)

    Fulltext@MSK | Save

    • Ferrata Storti Foundation – authorized name for: